Education
About Us
Working with TipRanks
Follow Us
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
RESEARCH TOOLSreports
Technical Sentiment
Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Brainstorm Cell Therapeutics’s (BCLI) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Brainstorm Cell Therapeutics is a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 20-Day exponential moving average is 1.14, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1.22, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) 50-Day exponential moving average is 1.26, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1.22, making it a Sell.
Brainstorm Cell Therapeutics (BCLI) Pivot Points
Classic
1.01
1.07
1.12
1.19
1.24
1.30
1.36
Fibonacci
1.07
1.11
1.14
1.19
1.23
1.26
1.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Brainstorm Cell Therapeutics (BCLI) Moving Averages
MA5
1.21Buy
1.21Buy
MA10
1.21Buy
1.18Buy
MA20
1.05Buy
1.14Buy
MA50
1.24Sell
1.26Sell
MA100
1.61Sell
1.61Sell
MA200
2.32Sell
2.67Sell
Brainstorm Cell Therapeutics’s (BCLI) 10-Day exponential moving average is 1.18, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1.22, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) 100-Day exponential moving average is 1.61, while Brainstorm Cell Therapeutics’s (BCLI) share price is $1.22, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $1.22 and Brainstorm Cell Therapeutics’s (BCLI) 50-day simple moving average is 1.24, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $1.22 and Brainstorm Cell Therapeutics’s (BCLI) 100-day simple moving average is 1.61, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $1.22 and Brainstorm Cell Therapeutics’s (BCLI) 200-day simple moving average is 2.32, creating a Sell signal.
Brainstorm Cell Therapeutics (BCLI) Technical Indicators
RSI (14)
54.34
Neutral
STOCH (9,6)
48.77
Neutral
STOCHRSI (14)
67.94
Neutral
MACD (12,26)
0.01
Sell
ADX (14)
35.17
Neutral
Williams %R
-29.85
Buy
CCI (14)
59.45
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
51.57
Neutral
ROC
38.64
Buy
Brainstorm Cell Therapeutics’s (BCLI) Relative Strength Index (RSI) is 54.34, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Trend Strength Indicator (ADX) is 35.17, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Commodity Channel Index (CCI) is 59.45, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Price Rate of Change (ROC) is 38.64, creating a Buy signal.
FAQ
Is BCLI a Buy, Hold, or Sell?
Based on BCLI’s technical indicators, BCLI is a Hold.
What is BCLI’s RSI (14)?
BCLI’s RSI (14) is 54.34, which suggests BCLI is a Neutral.
What is BCLI’s MACD?
BCLI’s MACD is 0.01, which suggests BCLI is a Sell.
What is BCLI’s 5-day moving average?
BCLI’s 5-day moving average is 1.21, which suggests BCLI is a Buy.
What is BCLI’s 20-day moving average?
BCLI 20-day moving average is 1.05, which suggests BCLI is a Buy.
What is BCLI’s 50-day moving average?
BCLI’s 50-day moving average is 1.24, which suggests BCLI is a Sell.
What is BCLI’s 200-day moving average?
BCLI’s 200-day moving average is 2.32, which suggests BCLI is a Sell.
What is BCLI’s Williams % R (14)?
BCLI’s Williams % R (14) is -29.85, which suggests BCLI is a Buy.
What is BCLI’s CCI (14)?
BCLI’s CCI (14) is 59.45, which suggests BCLI is a Neutral.